Weill Cornell Medicine/NewYork-Presbyterian Hospital
New York, New York 10065
29 studies enrolling now · 61 studies all time
What they study most
Ablation of Arrhythmia's, Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Lymphoid Leukemia, Acute Myeloid Leukemia, Allergic Reactions, B-Cell Lymphoma, Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), Blood Flow, Breast Cancer, CABG, CABG Graft Integrity
Studies at this site
- Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells — Recruiting now
- TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas — Recruiting now
- Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature — Recruiting now
- Neonatal Neurological Observation With Video AI — Recruiting now
- Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF) — Recruiting now
- BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies — Recruiting now
- A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Participants With Multiple Myeloma That is Resistant to Current Standard of Care Treatments — Recruiting now
- Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome — Recruiting now
- An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome — Recruiting now
- Study of 2 Medicines (Aztreonam and Avibactam) Compared to Best Available Therapy for Serious Gram-negative Infections — Recruiting now
- Platform Study of Immunotherapy Combinations in Colorectal Cancer Liver Metastases — Recruiting now
- Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection — Recruiting now
- Evaluation of Prostate Specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Active Surveillance for Prostate CancEr — Recruiting now
- Study of Suratadenoturev (OBP-301) in Combination With Pembrolizumab in Esophagogastric Adenocarcinoma — Recruiting now
- Phase II Study of Peptide Receptor Radionuclide Therapy in Combination With Immunotherapy for Patients With Merkel Cell Cancer — Recruiting now
- The Relationship Between Blood Flow Readings During Surgery and How Well the Graft Stays Open and How Patients Recover Afterward in Coronary Artery Bypass Graft Surgery — Recruiting now
- Study Evaluating the Safety and Efficacy of Neffy or Intramuscular Adrenalin in Patients With Allergic Reactions After Oral Food Challenge or Allergen Immunotherapy — Recruiting now
- Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors — Recruiting now
- Converting HR+ Breast Cancer Into an Individualized Vaccine — Recruiting now
- Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors — Recruiting now
- Study of TVB-2640 in Men With Metastatic Castration-Resistant Prostate Cancer — Recruiting now
- REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Minorities — Recruiting now
- STICH3C Cardiac Magnetic Resonance Observational Study — Recruiting now
- PRIMARY Ancillary Substudy — Recruiting now
- Oral Iron in Children With Chronic Kidney Disease — Recruiting now
- A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors — Recruiting now
- Early Feasibility Study of the Cardiac Implants Percutaneous Ring Annuloplasty System — Recruiting now
- A Study to Assess the Efficacy, Safety, Pharmacodynamics, and Pharmacokinetics of Tazemetostat in Combination With Lenalidomide Plus Rituximab Versus Placebo in Combination With Lenalidomide Plus Rituximab in Adult Patients at Least 18 Years of Age With Relapsed/Refractory Follicular Lymphoma. — Running, not enrolling
- Low-Dose TBI Plus CAR T-Cell Therapy for Relapsed/Refractory DLBCL and Multiple Myeloma — Starting soon
- Gilteritinib vs Midostaurin in FLT3 Mutated Acute Myeloid Leukemia — Completed
- Poly-omic Predictors of Symptom Duration and Recovery for Adolescent Concussion — Running, not enrolling
- A Study in Adult Participants With EoE to Evaluate Vonoprazan 20 mg Compared to Placebo After 12 Weeks and to Evaluate Vonoprazan 20 mg Up to 24 Weeks — Running, not enrolling
- Percutaneous or Surgical Repair In Mitral Prolapse And Regurgitation for ≥60 Year-olds (PRIMARY) — Running, not enrolling
- A Feasibility Trial of Tazemetostat Plus CAR T Cell Therapy in B-cell Lymphomas — Running, not enrolling
- Expanded Access Study for the Treatment of Patients With Commercially Out-of-Specification Axicabtagene Ciloleucel — Available (expanded access)
- A Study of Botensilimab in Participants With Metastatic Pancreatic Cancer — Completed
- Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study — Paused
- Pivotal Evaluation of Abdominal Neuromuscular Electrical Stimulation (VentFree) for Weaning From Mechanical Ventilation — Completed
- Precision-T: A Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies — Running, not enrolling
- A Study of CYP-001 in Combination With Corticosteroids in Adults With High-risk aGvHD — Running, not enrolling
- Combination Immunotherapy in Colorectal Cancer — Running, not enrolling
- A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures — Completed
- Long-term Safety and Efficacy Study and Dose-Escalation Substudy of PF 06838435 in Individuals With Hemophilia B — Running, not enrolling
- Expanded Access Study for the Treatment of Patients With Commercially Out-of-Specification Brexucabtagene Autoleucel — Available (expanded access)
- Tazemetostat and Mosunetuzumab in Untreated Follicular Lymphoma — Running, not enrolling
- Study to Assess the Occurrence of HPA-1a Alloimmunization in Women With Higher Risk for Fetal and Neonatal Alloimmune Thrombocytopenia — Completed
- Precision-T: A Randomized Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies — Running, not enrolling
- Radioembolization Trial Utilizing Eye90 Microspheres™ for the Treatment of Hepatocellular Carcinoma (HCC) — Running, not enrolling
- TRISCEND II Pivotal Trial — Running, not enrolling
- Nous-209 Genetic Vaccine for the Treatment of Microsatellite Unstable Solid Tumors — Running, not enrolling